The alternative sigma factor SigK has a role in stress tolerance of Clostridium botulinum

A study by DVM Elias Dahlsten and colleagues under Prof. Hannu Korkeala’s supervision suggests a previously unidentified role for the alternative sigma factor SigK in response and adaptation to low temperature and high salt conditions in Clostridium botulinum. The study was published in Applied and Environmental Microbiology.

C. botulinum ATCC 3502 wild type strain was1wt2
evaluated for relative sigK expression levels after cold shock, exposure to hyperosmotic conditions, exposure to acidity, or in optimal growth conditions, using quantitative reverse transcription PCR. Significant induction of sigK expression was observed upon temperature downshift and in hyperosmotic shock, but not in pH downshift or in optimal growth. Insertional inactivation of sigK with the ClosTron system resulted in a phenotype with impaired growth at low temperature and in high salt concentration, but with no difference in growth at optimal temperature or low pH conditions.

To date, SigK of clostridia has been strictly sporulation-associated. In this study, the researchers suggest a hitherto unidentified role for this alternative sigma factor in stress tolerance. Study of mechanisms by which the feared foodborne pathogen C. botulinum senses and responds to various environmental stresses it might encounter as hurdles applied in food preservation is of key importance. Identification of stress-activated genetic machineries of foodborne pathogens might provide biomarkers to exploit in detection of potentially stress-adapted cells, allowing targeted control methods.

The research was carried out at the Finnish Centre of Excellence in Microbial Food Safety Research and supported by the Academy of Finland, the Finnish Graduate School on Applied Bioscience, the European Community’s Seventh Framework Programme FP7/2007-2013 “CLOSTNET”, and the Walter Ehrström Foundation.

 

AntiBotABE meeting in Helsinki

The Department of Food Hygiene and Environmental Health and Professor Hannu Korkeala hosted the AntiBotABE meeting on 17-18th June in Helsinki. Centre Recherche Service Santé Armée supported by VITAMIB coordinates an international consortium on the development of neutralizing antibodies against botulinum toxins A, B, E.

It is a collaborative project under the EU’s 7th Research Framework Programme in the security research area. The AntiBotABE consortium contains of academic and industrial partners with the expertise to carry out highly innovative research and development in this exciting domain.

AntiBotABE_2013

Participants from Centre Recherche Service Santé Armée, France, Ministère de la Défense, France, Technische Universität Braunschweig, Germany, Institut Pasteur, France, Health Protection Agency HPA, United Kingdom, Centre National de la Recherche Scientifique, France, LFB Biotechnologies, France, University of Helsinki, Finland and VITAMIB, France shared and evaluated the recent developments in the AntiBotABE project and also experienced the Finnish summer.

>> Read more AntiBotABE